In rheumatoid arthritis patients with an inadequate response to anti-TNF therapy in the Attain trial, abatacept effectively reduced pain and fatigue, and improved sleep quality

Authors
Category Primary study
JournalJournal of Rheumatology
Year 2006
Loading references information
This article has no abstract
Epistemonikos ID: c6127628cd09ba1198f688e609b334acce898830
First added on: Oct 21, 2017